Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma
- 2 August 2012
- journal article
- Published by Springer Science and Business Media LLC in Infection
- Vol. 41 (1), 225-229
- https://doi.org/10.1007/s15010-012-0305-y
Abstract
A female patient with non-Hodgkin lymphoma who tested positive for surface antigen of the hepatitis B virus and negative for hepatitis B core antibody experienced a reactivation of occult HBV infection 20 months after rituximab discontinuation despite lamivudine prophylaxis covering the 4 months of rituximab administration and the subsequent 12 months.Keywords
This publication has 27 references indexed in Scilit:
- Surveillance and Treatment Protocols to Detect and Treat Hepatitis B Virus Reactivation in Hepatitis B Surface Antigen–Negative/Antibody to Hepatitis B Core Antigen–Positive Patients Receiving Chemotherapy for Onco-Hematologic MalignanciesJournal of Clinical Oncology, 2011
- Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination ChemotherapyJournal of Clinical Oncology, 2010
- Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B‐cell lymphoma patients who are HBsAg‐negative/ HBcAb‐positive: a multicenter retrospective studyEuropean Journal of Haematology, 2010
- Management of Hepatitis B Virus Reactivation in Patients with Hematological Malignancies Treated with ChemotherapyInfection, 2009
- EASL Clinical Practice Guidelines: Management of chronic hepatitis BJournal of Hepatology, 2009
- HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCVHepatology, 2008
- Chronic hepatitis BHepatology, 2007
- Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapyHepatology, 2006
- Hepatitis B Reactivation in Patients Positive for Hepatitis B Surface Antigen Undergoing Autologous Hematopoietic Cell TransplantationLeukemia & Lymphoma, 2003
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1993